Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

POC testing: the hospital bedside haemostasis market

This article was originally published in Clinica

Executive Summary

Coagulation testing products for use at the hospital bedside have been available for over three decades. International Technidyne Corporation (ITC) was the early pioneer, introducing the Hemochron point-of-care (POC) coagulation analyser in the 1970s for use in hospital operating rooms and other sites. Medtronic is another long-time supplier of POC coagulation systems. A number of new companies have since entered the market, including Roche Diagnostics, Pharmanetics (now part of Helena Labs), Instrumentation Laboratory (IL) and i-STAT/Abbott. POC platelet function testing, which is used to monitor patients undergoing platelet inhibitor therapy, comprises a growing segment of the market, and this is being addressed by companies including Siemens, Accumetrics, Helena Labs and Bio/Data.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel